The US FDA has approved Eli Lilly’s oral GLP-1 drug Foundayo, intensifying competition with Novo Nordisk and expanding access ...

The telehealth company Hims & Hers has formally initiated its partnership with Novo Nordisk, making FDA-approved GLP-1 medications such as Wegovy and Ozempi ...

Emcure slashes semaglutide injection price by 55%, prompting potential moves from Abbott to follow suit in India.

As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis. Megan Tatum reports.

Foundayo, a trademarked version of orforglipron, acts like the popular injectable medications that control appetite and ...

Emcure Pharmaceuticals reduces its semaglutide starting dose price by 55%, enhancing accessibility for obesity treatment in ...

The FDA approved Eli Lilly’s Foundayo, a pill-form GLP‑1 weight loss drug that offers a needle‑free option and could expand ...

Thursday's premiere kicked off with an introduction to Alicia and longtime fiancé Bill, with whom she shares daughter Celina.

The FDA recently approved a new oral GLP-1 weight loss medication from Eli Lilly, set to hit the market next week.

Coastal Carolina first-year head football coach Ryan Beard now has a better idea of what he’s working with as spring ...